MTOR and cancer: EC cells frequently show overactivation of PI3K/mTOR (∼50% of EC cells harbour a double allelic mutated PTEN gene) and canonical NF-kB pathways, which protect cancer cells from TRAIL-induced apoptosis [23, 24].